![]() |
New FDA approval expands use of AstraZeneca's Faslodex for women with HR+, HER2- meta
AstraZeneca today announced that the US Food and Drug Administration has approved a new indication in the US, expanding the use of Faslodex (fulvestrant) to include use in combination with Ibrance (palbociclib).
More... |
| All times are GMT -7. The time now is 06:23 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021